NIH-funded research R01 grant

Investigating how CD37 affects platelet responses in cardiovascular disease

Official title: CD37 as a Regulator of Platelet Patho(Physiological) Responses

Funded at New York University School of Medicine · NIH-10884199 · Data updated 2026-11-12

This study is looking at a protein called CD37 to see how it affects platelets in the blood, which could help us find new ways to prevent heart attacks and strokes without causing bleeding problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 15, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$579,849
NIH project number5R01HL167917-02
Project IDNIH-10884199 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of cardiovascular diseases, particularly those who have not yet experienced a heart attack or stroke.

Less likely to help

Patients who have already experienced multiple cardiovascular events or have existing severe bleeding disorders may not benefit from this research.

What this research studies

This research focuses on understanding the role of CD37, a novel regulator of platelet activation, in cardiovascular diseases such as myocardial infarction and stroke. By exploring how CD37 influences platelet behavior, the study aims to identify new therapeutic targets that could prevent these conditions without increasing the risk of bleeding. The approach includes advanced platelet sequencing to uncover the mechanisms by which platelets contribute to inflammation and atherosclerosis. This could lead to innovative treatments that improve cardiovascular health.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent heart attacks and strokes by targeting platelet functions without the risk of major bleeding.

How similar studies have gone: Previous research has shown promise in targeting platelet functions for cardiovascular disease prevention, indicating that this approach could be a significant advancement in treatment options.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Barrett, Tessa — New York University School of Medicine
  • Study coordinator: Barrett, Tessa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.